Literature DB >> 8301350

GAP-43 transgenic mice: dispersed genomic sequences confer a GAP-43-like expression pattern during development and regeneration.

J Vanselow1, E Grabczyk, J Ping, M Baetscher, S Teng, M C Fishman.   

Abstract

Using transgenic mice, we have examined the expression pattern conferred by regions of genomic GAP-43 coupled to beta-galactosidase. We demonstrate that gene constructions that include the GAP-43 5'-flanking region along with sufficient sequences of the first intron drive beta-galactosidase (lacZ) expression to mimic in many regards the complex spatial and temporal pattern of endogenous GAP-43 expression. Transgene expression reaches peak levels during development, and persists at high levels in particular adult brain regions, such as the hippocampus and olfactory bulb. The inclusion of a stretch of the first intron in the construction is necessary to prevent expression outside of the nervous system, indicating that some of the cell specificity of GAP-43 expression is due to suppression of expression in inappropriate tissues. Injury caused by sciatic nerve crush causes reexpression of the transgene in adult sensory and motor neurons. This genomic region of GAP-43, therefore, includes elements responsive to neuronal growth signals that regulate both development and regeneration.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8301350      PMCID: PMC6576807     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  21 in total

1.  Intron 1 is required for cell type-specific, but not injury-responsive, peripherin gene expression.

Authors:  Thomas E Uveges; Yuqing Shan; Bridget E Kramer; David C Wight; Linda M Parysek
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

2.  Nerve growth factor controls GAP-43 mRNA stability via the phosphoprotein ARPP-19.

Authors:  Nina Irwin; Steven Chao; Luda Goritchenko; Atsuko Horiuchi; Paul Greengard; Angus C Nairn; Larry I Benowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-09       Impact factor: 11.205

3.  Long-term potentiation activates the GAP-43 promoter: selective participation of hippocampal mossy cells.

Authors:  U Namgung; S Matsuyama; A Routtenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

4.  Identification of a novel repressive element that contributes to neuron-specific gene expression.

Authors:  J R Weber; J H Skene
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

5.  Coordinated expression of HuD and GAP-43 in hippocampal dentate granule cells during developmental and adult plasticity.

Authors:  Federico Bolognani; Daniel C Tanner; Sayuri Nixon; Hirotaka J Okano; Hideyuki Okano; Nora I Perrone-Bizzozero
Journal:  Neurochem Res       Date:  2007-06-19       Impact factor: 3.996

6.  3.6 kb genomic sequence from Takifugu capable of promoting axon growth-associated gene expression in developing and regenerating zebrafish neurons.

Authors:  Ava J Udvadia
Journal:  Gene Expr Patterns       Date:  2008-05-24       Impact factor: 1.224

7.  Identification of cis-acting sequences in the promoter of the herpes simplex virus type 1 latency-associated transcripts required for activation by nerve growth factor and sodium butyrate in PC12 cells.

Authors:  D P Frazier; D Cox; E M Godshalk; P A Schaffer
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

8.  Post-transcriptional regulation of the GAP-43 gene by specific sequences in the 3' untranslated region of the mRNA.

Authors:  K C Tsai; V V Cansino; D T Kohn; R L Neve; N I Perrone-Bizzozero
Journal:  J Neurosci       Date:  1997-03-15       Impact factor: 6.167

9.  Identification of two proteins that bind to a pyrimidine-rich sequence in the 3'-untranslated region of GAP-43 mRNA.

Authors:  N Irwin; V Baekelandt; L Goritchenko; L I Benowitz
Journal:  Nucleic Acids Res       Date:  1997-03-15       Impact factor: 16.971

Review 10.  Maintaining the neuronal phenotype after injury in the adult CNS. Neurotrophic factors, axonal growth substrates, and gene therapy.

Authors:  M H Tuszynski; F H Gage
Journal:  Mol Neurobiol       Date:  1995 Apr-Jun       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.